Panimus Integration

Panimus Integration Paul Antico: Rosen Method Bodywork, Compassionate Inquiry Practitioner. PSIP, Psychedelic Integration & Support. This happens monthly.

I am privileged to be your guide on the often challenging but rewarding journey of healing. I recognize your essence underneath the issues, and support your connection with your own essence-tial self. Gabor Maté’s Compassionate Inquiry is an elegant somatic based system that supports understanding, growth and healing, providing insight through direct experience. As a Certified CI Practitioner, I s

upport others in their healing journey through life, providing a safe space to explore the triggers, traumas, and issues that get in the way of connection, expression, and living life in-joy, with presence and acceptance. I am sensitive, compassionate, and thoughtful, as I know the trauma territory firsthand from my own challenging journey. I also work in the realm of Psychedelics/Plant Medicines/Entheogens in a number of ways to support deep healing from connecting with our core beliefs. I am a Psychedelic Somatic Interactional Therapist (through the Psychedelic Somatic Institute, psychedelicsomatic.org)

Psychedelic integration is working with the insights, visions, sensations and feelings received during or after a psychedelic journey, and applying them to your day-to-day life for healing, growth, and positive changes. I provide individual and group Psychedelic Integration Sessions. I lead the Downtown Los Angeles Community Psychedelic Integration Circle as part of PsychedeLiA Integration. Check the Psychedelia Integration Facebook Group, Psychedelia Meet-up Group or Psychedelia Eventbrite for details on when these are offered. Psychedelia has other great Circle Leaders that lead circles as well. I also work with individuals with a wonderful female partner, for those that appreciate the benefit of working with both the feminine and masculine supporting their process.

https://plantspiritschool.com/gmt-PaulA
11/15/2024

https://plantspiritschool.com/gmt-PaulA

Are you curious about how compassionate inquiry can enhance your trauma-informed entheogenic medicine practice when working with yourself or others for deeper understanding and healing?

Choose your facilitators wisely! Are medical trainees ready for psychedelics?With the U.S. Food and Drug Administration ...
04/27/2024

Choose your facilitators wisely!
Are medical trainees ready for psychedelics?

With the U.S. Food and Drug Administration months away from deciding whether MDMA-assisted therapy should be approved for medical use in treating PTSD, and more states considering regulated psychedelic programs, there could soon be heightened demand for psychedelic-assisted therapy. But according to data published in The Journal of Psychoactive Drugs this week, medical trainees are “unprepared for advances in psychedelic medicine.” Researchers at the University of Michigan, Wayne State, and SUNY Buffalo analyzed survey results from over 200 trainees in programs in medicine, pharmacy, psychology, social work, and biological science. Only 10 percent reported receiving any training in psychedelic medicine or psychotherapy, and most reported that their knowledge about psychedelics came from word of mouth, social media, or popular media.

Participants were also asked 12 questions to assess their knowledge of psychedelics. Questions included, “What is the main psychoactive ingredient in ayahuasca?” and “Under which category are psychedelic drugs scheduled in the United States?” Over a quarter of participants answered none of the questions correctly, and the average score was 31 percent. “The survey indicated that overall knowledge surrounding psychedelic science and medicine is quite low,” the authors wrote. In considering these results alongside another recent study showing that nearly 80 percent of psychiatrists said they’d been asked about psychedelic-assisted therapies by patients or families, the researchers note that a lack of knowledge could stymie the development of psychedelic therapies. “Lack of adequate knowledge among trainees carries the risk of creating biases and prejudices against these novel treatments and could result in a decreased number of adequately trained medical professionals who are able to carry out psychedelic-assisted therapies,” they write.

This study aimed to characterize attitudes and identify gaps in trainee knowledge and education that may impact the field’s readiness for the reemergence of psychedelic use in psychiatry. A two-par...

Psychedelic comedian Shane Mauss live in Los Angeles! Five dollars off tickets use code GPS Global Psychedelic Society
03/29/2024

Psychedelic comedian Shane Mauss live in Los Angeles! Five dollars off tickets use code GPS Global Psychedelic Society

This Tuesday eve! Integration Circle to explore your journeys or find out about working with psychedelics.
03/25/2024

This Tuesday eve! Integration Circle to explore your journeys or find out about working with psychedelics.

Join us for our integration and discussion circle around psychedelic experiences, and to hold space for, or receive somatic integration.

03/21/2024

From Psychedelic Alpha:

Whole Mushroom vs. Synthetic Psilocybin

Scottsdale Research Institute’s Sue Sisley gave two talks at SXSW. In both appearances, Sisley was keen to highlight the fact that clinical research into psychedelics has neglected to study whole-mushroom psilocybin, instead opting to investigate synthetic preparations of the drug.

When psilocybin is ingested as part of the whole mushroom it’s naturally found in, Sisley said, ‘all the molecules work in concert with each other’ to achieve a ‘natural balance’. The researcher has made it her mission to run such studies.

And it looks like she might be about to do so: Sisley shared that her group at the Scottsdale Research Institute has been awarded $2.75m from Arizona state funding for a Phase I study of whole psilocybin mushrooms in patients with life-threatening diseases.

While the study will primarily be geared towards assessing safety, Sisley and co. will try to get an early read on the mushrooms’ anxiolytic potential. You can read more about the project by reviewing the grant documents.

Sisley acknowledged that it would be tough to get whole mushroom preparations past Phase I, given GMP requirements. But it’s certainly an interesting study, especially given the provision of state funding.

Shortly before SXSW, a paper from the Hadassah BrainLabs Center for Psychedelic Research was published in Molecular Psychiatry (Shahar et al., 2024). The researchers sought to compare the effects of chemically synthesized psilocybin (provided by Usona Institute) with whole mushroom extract in mice.

The researchers concluded that psilocybin mushroom extract “has a more potent and prolonged effect on synaptic plasticity” than synthetic psilocybin. While they acknowledge further studies are needed, the authors’ contribution makes a compelling case for more exploration of the polypharmacology or ‘entourage effect’ of mushrooms.

Tomorrow, Feb 27, IN-PERSON Circle!
02/27/2024

Tomorrow, Feb 27, IN-PERSON Circle!

Join us for our integration and discussion circle around psychedelic experiences, and to hold space for, or receive somatic integration.

Jungian Therapy
02/23/2024

Jungian Therapy

Since the 1990s several research projects and empirical studies (process and outcome) on Jungian Psychotherapy have been conducted mainly in Germany and Switzerland. Prospective, naturalistic outcome studies and retrospective studies using standardized instruments and health insurance data as well a...

02/23/2024

Keto diet and mental health?

This Saturday at 6:30 pm!
02/23/2024

This Saturday at 6:30 pm!

Discover a unique fusion of cannabis, movement, sound, and integration!

Address

South Los Angeles, CA
90015

Website

Alerts

Be the first to know and let us send you an email when Panimus Integration posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share